Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction

H Hakonarson; S Thorvaldsson; A. Helgadottir; Daniel Gudbjartsson; Florian Zink; Margret Andresdottir; Davíð Ottó Arnar; K Andersen; A Sigurdsson; Guðmundur Thorgeirsson; A Jonsson; U Agnarsson; H Bjornsdottir; Gizur Gottskalksson; A. Einarsson; H Gudmundsdottir; K Gudmundsson; Asdis E. Adalsteinsdottir; K. Kristjansson; T Hardarson; A Kristinsson; Eric J. Topol; J Gulcher; A Kong; Mark Gurney; G Thorgeirsson; K. Stefansson

Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction

H Hakonarson, S Thorvaldsson, A. Helgadottir, Daniel Gudbjartsson, Florian Zink, Margret Andresdottir, Davíð Ottó Arnar, K Andersen, A Sigurdsson, Guðmundur Thorgeirsson, A Jonsson, U Agnarsson, H Bjornsdottir, Gizur Gottskalksson, A. Einarsson, H Gudmundsdottir, K Gudmundsson, Asdis E. Adalsteinsdottir, K. Kristjansson, T HardarsonA Kristinsson, Eric J. Topol, J Gulcher, A Kong, Mark Gurney, G Thorgeirsson, K. Stefansson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2245-2256
Number of pages	11
Journal	JAMA
Volume	293
Publication status	Published - 2005

Cite this

Hakonarson, H., Thorvaldsson, S., Helgadottir, A., Gudbjartsson, D., Zink, F., Andresdottir, M., Arnar, D. O., Andersen, K., Sigurdsson, A., Thorgeirsson, G., Jonsson, A., Agnarsson, U., Bjornsdottir, H., Gottskalksson, G., Einarsson, A., Gudmundsdottir, H., Gudmundsson, K., Adalsteinsdottir, A. E., Kristjansson, K., ... Stefansson, K. (2005). Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction. JAMA, 293, 2245-2256.

@article{d62c817ea93346dc85e1b207baf5f1e7,

title = "Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction",

author = "H Hakonarson and S Thorvaldsson and A. Helgadottir and Daniel Gudbjartsson and Florian Zink and Margret Andresdottir and Arnar, {Dav{\'i}{\dh} Ott{\'o}} and K Andersen and A Sigurdsson and Gu{\dh}mundur Thorgeirsson and A Jonsson and U Agnarsson and H Bjornsdottir and Gizur Gottskalksson and A. Einarsson and H Gudmundsdottir and K Gudmundsson and Adalsteinsdottir, {Asdis E.} and K. Kristjansson and T Hardarson and A Kristinsson and Topol, {Eric J.} and J Gulcher and A Kong and Mark Gurney and G Thorgeirsson and K. Stefansson",

year = "2005",

language = "English",

volume = "293",

pages = "2245--2256",

journal = "JAMA",

issn = "1538-3598",

publisher = "American Medical Association",

}

Hakonarson, H, Thorvaldsson, S, Helgadottir, A, Gudbjartsson, D, Zink, F, Andresdottir, M, Arnar, DO, Andersen, K, Sigurdsson, A, Thorgeirsson, G, Jonsson, A, Agnarsson, U, Bjornsdottir, H, Gottskalksson, G, Einarsson, A, Gudmundsdottir, H, Gudmundsson, K, Adalsteinsdottir, AE, Kristjansson, K, Hardarson, T, Kristinsson, A, Topol, EJ, Gulcher, J, Kong, A, Gurney, M, Thorgeirsson, G & Stefansson, K 2005, 'Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction', JAMA, vol. 293, pp. 2245-2256.

TY - JOUR

T1 - Effects of a 5-lipoxygnease-activating protein inhibitor on biomarkers associated with risk of myocardial infarction

AU - Hakonarson, H

AU - Thorvaldsson, S

AU - Helgadottir, A.

AU - Gudbjartsson, Daniel

AU - Zink, Florian

AU - Andresdottir, Margret

AU - Arnar, Davíð Ottó

AU - Andersen, K

AU - Sigurdsson, A

AU - Thorgeirsson, Guðmundur

AU - Jonsson, A

AU - Agnarsson, U

AU - Bjornsdottir, H

AU - Gottskalksson, Gizur

AU - Einarsson, A.

AU - Gudmundsdottir, H

AU - Gudmundsson, K

AU - Adalsteinsdottir, Asdis E.

AU - Kristjansson, K.

AU - Hardarson, T

AU - Kristinsson, A

AU - Topol, Eric J.

AU - Gulcher, J

AU - Kong, A

AU - Gurney, Mark

AU - Thorgeirsson, G

AU - Stefansson, K.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1538-3598

VL - 293

SP - 2245

EP - 2256

JO - JAMA

JF - JAMA

ER -